In Vivo Evaluation of a New Recombinant Hyaluronidase to Improve Gene Electro-Transfer Protocols for DNA-Based Drug Delivery against Cancer

Cancer vaccines based on plasmid DNA represent a good therapeutic perspective, despite their low potency. Animal-derived hyaluronidases (Hyals) are employed in oncological clinical practice. Hyal has been also demonstrated to be a good enhancer of intramuscular Gene Electro-Transfer (GET) efficiency...

Descripción completa

Detalles Bibliográficos
Autores principales: De Robertis, Mariangela, Pasquet, Lise, Loiacono, Luisa, Bellard, Elisabeth, Messina, Luciano, Vaccaro, Susanna, Di Pasquale, Roberta, Fazio, Vito Michele, Rols, Marie-Pierre, Teissie, Justin, Golzio, Muriel, Signori, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265783/
https://www.ncbi.nlm.nih.gov/pubmed/30373297
http://dx.doi.org/10.3390/cancers10110405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265783/
https://www.ncbi.nlm.nih.gov/pubmed/30373297
http://dx.doi.org/10.3390/cancers10110405

Ejemplares similares